TLCD4
gene geneOn this page
Also known as FLJ31842
Summary
TLCD4 (TLC domain containing 4, HGNC:26477) is a protein-coding gene on chromosome 1p21.3, encoding TLC domain-containing protein 4 (Q96MV1).
Predicted to be involved in lipid homeostasis. Predicted to be located in membrane. Predicted to be active in endoplasmic reticulum.
Source: NCBI Gene 148534 — RefSeq curated summary.
At a glance
- GWAS associations: 10
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_152487
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26477 |
| Approved symbol | TLCD4 |
| Name | TLC domain containing 4 |
| Location | 1p21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ31842 |
| Ensembl gene | ENSG00000152078 |
| Ensembl biotype | protein_coding |
| Entrez | 148534 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 15 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000370203, ENST00000455656, ENST00000456991, ENST00000463375, ENST00000882686, ENST00000882687, ENST00000882688, ENST00000882689, ENST00000882690, ENST00000882691, ENST00000882692, ENST00000882693, ENST00000882694, ENST00000882695, ENST00000882696, ENST00000941043
RefSeq mRNA: 2 — MANE Select: NM_152487
NM_001199679, NM_152487
CCDS: CCDS753
Canonical transcript exons
ENST00000370203 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001452059 | 95191550 | 95197607 |
| ENSE00001452064 | 95117355 | 95117617 |
| ENSE00003484007 | 95173816 | 95173889 |
| ENSE00003486151 | 95151325 | 95151419 |
| ENSE00003565921 | 95148702 | 95148791 |
| ENSE00003583841 | 95150208 | 95150266 |
| ENSE00003656095 | 95143891 | 95144056 |
Expression profiles
Bgee: expression breadth ubiquitous, 231 present calls, max score 96.53.
FANTOM5 (CAGE): breadth broad, TPM avg 4.7724 / max 242.8384, expressed in 910 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 4122 | 4.4756 | 900 |
| 4123 | 0.2968 | 127 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left ventricle myocardium | UBERON:0006566 | 96.53 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 95.79 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 94.98 | gold quality |
| liver | UBERON:0002107 | 94.27 | gold quality |
| myocardium | UBERON:0002349 | 93.72 | gold quality |
| right lobe of liver | UBERON:0001114 | 92.79 | gold quality |
| upper leg skin | UBERON:0004262 | 91.57 | gold quality |
| ileal mucosa | UBERON:0000331 | 90.42 | gold quality |
| heart right ventricle | UBERON:0002080 | 90.41 | gold quality |
| colonic epithelium | UBERON:0000397 | 90.19 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 89.56 | gold quality |
| bone marrow | UBERON:0002371 | 86.74 | gold quality |
| mammalian vulva | UBERON:0000997 | 86.38 | gold quality |
| bone marrow cell | CL:0002092 | 86.30 | gold quality |
| endothelial cell | CL:0000115 | 85.56 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 85.38 | silver quality |
| colonic mucosa | UBERON:0000317 | 84.35 | gold quality |
| rectum | UBERON:0001052 | 84.06 | gold quality |
| cardiac atrium | UBERON:0002081 | 83.83 | gold quality |
| deltoid | UBERON:0001476 | 83.55 | gold quality |
| cardiac ventricle | UBERON:0002082 | 83.44 | gold quality |
| heart | UBERON:0000948 | 83.40 | gold quality |
| heart left ventricle | UBERON:0002084 | 83.34 | gold quality |
| right atrium auricular region | UBERON:0006631 | 83.25 | gold quality |
| biceps brachii | UBERON:0001507 | 83.07 | gold quality |
| upper arm skin | UBERON:0004263 | 82.95 | silver quality |
| adrenal tissue | UBERON:0018303 | 82.90 | gold quality |
| vastus lateralis | UBERON:0001379 | 82.45 | gold quality |
| muscle tissue | UBERON:0002385 | 82.38 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 82.34 | gold quality |
Single-cell (SCXA)
Detected in 8 experiment(s), a significant marker in 7.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-112 | yes | 57.19 |
| E-MTAB-10042 | yes | 40.45 |
| E-GEOD-135922 | yes | 16.19 |
| E-MTAB-9388 | yes | 7.62 |
| E-MTAB-9067 | yes | 5.80 |
| E-HCAD-10 | yes | 3.88 |
| E-GEOD-75367 | no | 697.97 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
293 targeting TLCD4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-340-5P | 100.00 | 72.50 | 4437 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:dkey-10f21.4 | ENSDARG00000057743 |
| danio_rerio | tlcd4a | ENSDARG00000098451 |
| mus_musculus | Tlcd4 | ENSMUSG00000028132 |
| rattus_norvegicus | Tlcd4 | ENSRNOG00000025160 |
Paralogs (5): TLCD3B (ENSG00000149926), TLCD1 (ENSG00000160606), TLCD3A (ENSG00000167695), CLN8 (ENSG00000182372), TLCD2 (ENSG00000185561)
Protein
Protein identifiers
TLC domain-containing protein 4 — Q96MV1 (reviewed: Q96MV1)
Alternative names: Transmembrane protein 56
All UniProt accessions (3): Q96MV1, C9J6J2, C9JJM2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Similarity. Belongs to the TLCD4 family.
RefSeq proteins (2): NP_001186608, NP_689700* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR006634 | TLC-dom | Domain |
| IPR050846 | TLCD | Family |
Pfam: PF03798
UniProt features (9 total): transmembrane region 6, chain 1, domain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96MV1-F1 | 94.27 | 0.87 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 165
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 190 (showing top):
RNGTGGGC_UNKNOWN, LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, IVANOVA_HEMATOPOIESIS_MATURE_CELL, GOBP_LIPID_HOMEOSTASIS, MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN, MCBRYAN_PUBERTAL_BREAST_3_4WK_UP, MCBRYAN_PUBERTAL_BREAST_5_6WK_UP, GUO_HEX_TARGETS_DN, HOOI_ST7_TARGETS_DN, LE_EGR2_TARGETS_DN, chr1p21, EVI1_04, SENESE_HDAC3_TARGETS_DN, GOBP_HOMEOSTATIC_PROCESS
GO Biological Process (1): lipid homeostasis (GO:0055088)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): endoplasmic reticulum (GO:0005783), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| chemical homeostasis | 1 |
| binding | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
912 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TLCD4 | METTL8 | Q9H825 | 647 |
| TLCD4 | HEXIM2 | Q96MH2 | 562 |
| TLCD4 | MBOAT2 | Q6ZWT7 | 496 |
| TLCD4 | SMIM3 | Q9BZL3 | 493 |
| TLCD4 | GATA1 | P15976 | 446 |
| TLCD4 | CCDC74A | Q96AQ1 | 437 |
| TLCD4 | NOCT | Q9UK39 | 426 |
| TLCD4 | DNAJC6 | O75061 | 422 |
| TLCD4 | GFI1B | Q5VTD9 | 419 |
| TLCD4 | ITGA2B | P08514 | 415 |
| TLCD4 | LRRN4CL | Q8ND94 | 382 |
| TLCD4 | HEMGN | Q9BXL5 | 370 |
| TLCD4 | RWDD3 | Q9Y3V2 | 369 |
| TLCD4 | NRIP2 | Q9BQI9 | 363 |
| TLCD4 | RGS7BP | Q6MZT1 | 353 |
IntAct
256 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM19 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CHPT1 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NKG7 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| REEP6 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| EMP1 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM229B | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BNIP3 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EBP | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLCD4 | CLEC7A | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLCD4 | MYG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYP4F22 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FDFT1 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CMTM5 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLCD4 | CCDC167 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLCD4 | UBE2J1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLCD4 | SFXN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TLCD4 | SERP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FA2H | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXCL16 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM120B | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| COMT | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (117): TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Affinity Capture-MS), TMEM56 (Two-hybrid), TMEM56 (Two-hybrid)
ESM2 similar proteins: A2AKM2, A2AWR3, A8MR93, A8WGS4, D4A612, F1NZP5, G5EF48, O13752, O70536, P47153, Q0P5C7, Q0VD42, Q1A3B0, Q1LXV8, Q32NI8, Q3TYE7, Q4R516, Q500W7, Q57X51, Q5M8U1, Q5ND56, Q5RFL5, Q5U2T1, Q5XIY2, Q60457, Q6GLX2, Q6GNB5, Q6P4N1, Q6PGS5, Q6YWS8, Q6ZRR5, Q84QC0, Q8BHI7, Q8CGF5, Q8GYK7, Q8IU89, Q8K2C9, Q8N609, Q8QZR0, Q96CP7
Diamond homologs: O13752, Q06107, Q5UQN8, Q96MV1, P47153, Q55BP8, Q6GLX2, Q6PGS5, Q8CGF5, Q5XIY2, Q6P4N1, Q8VC26
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1715 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:95138380:G:GT | donor_gain | 1.0000 |
| 1:95138400:G:T | donor_gain | 1.0000 |
| 1:95143885:TAACA:T | acceptor_loss | 1.0000 |
| 1:95143886:AACAG:A | acceptor_loss | 1.0000 |
| 1:95143887:ACAGG:A | acceptor_loss | 1.0000 |
| 1:95143888:CAG:C | acceptor_loss | 1.0000 |
| 1:95143888:CAGGT:C | acceptor_loss | 1.0000 |
| 1:95143889:A:AT | acceptor_loss | 1.0000 |
| 1:95143890:G:C | acceptor_loss | 1.0000 |
| 1:95148701:GGGTA:G | acceptor_gain | 1.0000 |
| 1:95150206:A:AG | acceptor_gain | 1.0000 |
| 1:95150206:AG:A | acceptor_gain | 1.0000 |
| 1:95150206:AGG:A | acceptor_gain | 1.0000 |
| 1:95150207:G:GG | acceptor_gain | 1.0000 |
| 1:95150207:GG:G | acceptor_gain | 1.0000 |
| 1:95150207:GGG:G | acceptor_gain | 1.0000 |
| 1:95150207:GGGGT:G | acceptor_gain | 1.0000 |
| 1:95150264:CTGG:C | donor_loss | 1.0000 |
| 1:95150267:G:T | donor_loss | 1.0000 |
| 1:95150268:T:G | donor_loss | 1.0000 |
| 1:95173802:T:G | acceptor_gain | 1.0000 |
| 1:95173814:A:AG | acceptor_gain | 1.0000 |
| 1:95173815:G:GG | acceptor_gain | 1.0000 |
| 1:95173886:AGCGG:A | donor_loss | 1.0000 |
| 1:95173887:GCG:G | donor_gain | 1.0000 |
| 1:95173887:GCGGT:G | donor_loss | 1.0000 |
| 1:95173888:CGG:C | donor_loss | 1.0000 |
| 1:95173888:CGGT:C | donor_loss | 1.0000 |
| 1:95173890:G:GA | donor_loss | 1.0000 |
| 1:95173890:G:GG | donor_gain | 1.0000 |
AlphaMissense
1740 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:95144046:T:A | W49R | 0.997 |
| 1:95144046:T:C | W49R | 0.997 |
| 1:95173870:A:C | S152R | 0.996 |
| 1:95173872:C:A | S152R | 0.996 |
| 1:95173872:C:G | S152R | 0.996 |
| 1:95191626:T:C | F184L | 0.994 |
| 1:95191628:C:A | F184L | 0.994 |
| 1:95191628:C:G | F184L | 0.994 |
| 1:95191766:T:A | N230K | 0.993 |
| 1:95191766:T:G | N230K | 0.993 |
| 1:95173884:T:A | N156K | 0.991 |
| 1:95173884:T:G | N156K | 0.991 |
| 1:95191773:T:A | W233R | 0.991 |
| 1:95191773:T:C | W233R | 0.991 |
| 1:95143944:A:C | S15R | 0.990 |
| 1:95143946:C:A | S15R | 0.990 |
| 1:95143946:C:G | S15R | 0.990 |
| 1:95143980:A:C | S27R | 0.990 |
| 1:95143982:T:A | S27R | 0.990 |
| 1:95143982:T:G | S27R | 0.990 |
| 1:95151381:C:G | H121D | 0.990 |
| 1:95173850:G:C | R145P | 0.990 |
| 1:95173868:C:T | S151F | 0.989 |
| 1:95173889:G:C | R158P | 0.989 |
| 1:95148702:G:C | R52S | 0.988 |
| 1:95148702:G:T | R52S | 0.988 |
| 1:95191639:G:C | R188P | 0.988 |
| 1:95144048:G:C | W49C | 0.986 |
| 1:95144048:G:T | W49C | 0.986 |
| 1:95151325:A:C | D102A | 0.986 |
dbSNP variants (sampled 300 via entrez): RS1000014289 (1:95153048 C>A,G), RS1000017455 (1:95136425 A>G), RS1000048224 (1:95136927 G>A,T), RS1000084500 (1:95101972 G>A,T), RS1000133360 (1:95193378 A>G), RS1000161443 (1:95125732 G>A), RS1000173242 (1:95114562 A>G), RS1000186695 (1:95173344 C>T), RS1000210456 (1:95143668 T>C,G), RS1000217721 (1:95173081 A>G), RS1000232835 (1:95150828 C>T), RS1000264032 (1:95151128 A>G), RS1000285317 (1:95150576 A>C), RS1000299256 (1:95173969 CAA>C), RS1000318959 (1:95131409 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
10 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001838_4 | Palmitic acid (16:0) levels | 3.000000e-11 |
| GCST001840_8 | Stearic acid (18:0) levels | 2.000000e-18 |
| GCST002701_35 | Verbal declarative memory | 9.000000e-06 |
| GCST008103_62 | Bipolar disorder | 6.000000e-07 |
| GCST008103_84 | Bipolar disorder | 1.000000e-06 |
| GCST009028_33 | Adverse response to drug | 5.000000e-07 |
| GCST009391_1620 | Metabolite levels | 4.000000e-06 |
| GCST011125_14 | Caffeine consumption from coffee | 9.000000e-11 |
| GCST012091_10 | Bipolar disorder (MTAG) | 1.000000e-08 |
| GCST90002401_350 | Platelet distribution width | 8.000000e-18 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
| EFO:0006805 | word list delayed recall measurement |
| EFO:0009658 | adverse effect |
| EFO:0010379 | phosphatidylcholine 36:1 measurement |
| EFO:0006781 | coffee consumption measurement |
| EFO:0007984 | platelet component distribution width |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, decreases methylation | 5 |
| potassium chromate(VI) | affects cotreatment, decreases expression | 2 |
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| Nickel | decreases expression | 2 |
| Aflatoxin B1 | decreases expression, decreases methylation | 2 |
| aristolochic acid I | decreases expression | 1 |
| methylmercuric chloride | decreases expression, increases expression | 1 |
| trichostatin A | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| epigallocatechin gallate | affects cotreatment, decreases expression | 1 |
| pentanal | decreases expression | 1 |
| chromium hexavalent ion | decreases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| perfluoro-n-nonanoic acid | affects methylation | 1 |
| entinostat | increases expression | 1 |
| clothianidin | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Vorinostat | increases expression | 1 |
| Calcitriol | increases expression, affects cotreatment | 1 |
| Cisplatin | decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Estradiol | affects cotreatment, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Testosterone | affects cotreatment, increases expression | 1 |
| Toluene | decreases methylation, increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Vanadates | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TT02 | HAP1 TMEM56 (-) 1 | Cancer cell line | Male |
| CVCL_TT03 | HAP1 TMEM56 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.